Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot?

Journal of Nuclear Medicine

Volumn 52, Issue 7, 2011, Pages 1012-1019

  Familiari, Demetrio ^a   Glaudemans, Andor W J M ^b   Vitale, Valeria ^c   Prosperi, Daniela ^a   Bagni, Oreste ^a   Lenza, Andrea ^a   Cavallini, Marco ^c   Scopinaro, Francesco ^a   Signore, Alberto ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Diabetic foot; Infection; Osteomyelitis; PET CT; White blood cell scintigraphy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; BONE BIOPSY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIABETIC FOOT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE SCINTIGRAPHY; MALE; OSTEOMYELITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEUS MIRABILIS; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SKIN ULCER; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS AGALACTIAE; COMPUTER ASSISTED TOMOGRAPHY; IMAGE PROCESSING; LEUKOCYTE; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING; TIME;

AGED; AGED, 80 AND OVER; DIABETIC FOOT; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEUKOCYTES; MALE; MIDDLE AGED; OSTEOMYELITIS; POSITRON-EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SOFT TISSUE INFECTIONS; TECHNETIUM TC 99M EXAMETAZIME; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960292948     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.082222     Document Type: Article

References (19)

1. Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun. 2006;27:757-764. (Pubitemid 44401242)
2. 18F-FDG PET/CT. J Nucl Med. 2005;46:444-449.
3. Ramsey SD, Newton K, Blough D, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999;22:382-387. (Pubitemid 29106890)
4. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg. 1998;176(2A, suppl):5S-10S.
5. Gierbolini R. Charcot's foot: often overlooked complication of diabetes. JAAPA. 1999;12:62-68.
6. Ertugrul MB, Baktiroglu S, Salman S, et al. The diagnosis of osteomyelitis of the foot in diabetes: microbiological examination vs. magnetic resonance imaging and labelled leucocyte scanning. Diabet Med. 2006;23:649-653. (Pubitemid 43830066)
7. Wheat LJ, Allen SD, Henry M, et al. Diabetic foot infections: bacteriologic analysis. Arch Intern Med. 1986;146:1935-1940. (Pubitemid 16006683)
8. Tomas MB, Patel M, Marwin SE, Palestro CJ. The diabetic foot. Br J Radiol. 2000;73:443-450. (Pubitemid 30251358)
9. Blume PA, Dey HM, Daley LJ, Arrighi JA, Soufer R, Gorecki GA. Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes. J Foot Ankle Surg. 1997;36:120-126. (Pubitemid 27183768)
10. Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers: diagnosis and monitoring by leukocyte scanning with indium in 111 oxyquinoline. JAMA. 1991;266:1246-1251.
11. Datz FL, Seabold JE, Brown ML, et al. Procedure guideline for technetium-99m-HMPAO-labeled leukocyte scintigraphy for suspected infection/inflammation. Society of Nuclear Medicine. J Nucl Med. 1997;38:987-990. (Pubitemid 27252000)
12. 99mTc-HMPAO. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:842-848.
13. 111In-Leukocyte Scintigraphy for Suspected Infection/Inflammation. Reston, VA: Society of Nuclear Medicine; 2004.
14. Roca M, Martin-Comin J, Becker W, et al. A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime. International Society of Radiolabeled Blood Elements (ISORBE). Eur J Nucl Med. 1998;25:797-799. (Pubitemid 28377045)
15. 111In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging. 2010;37:835-841.
16. Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2009;39:36-51.
17. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2000;16(suppl 1):S84-S92.
18. Nawaz A, Torigian DA, Siegelman ES, Basu S, Chryssikos T, Alavi A. Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot. Mol Imaging Biol. 2010;12:335-342.
19. Schwegler B, Stumpe KD, Weishaupt D, et al. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. J Intern Med. 2008;263:99-106. (Pubitemid 350243549)